✦ LIBER ✦

Anti-inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine?

✍ Scribed by Fen-Ling Fan; Anthony M Dart

Book ID: 115170621
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 496 KB
Volume: 39
Category: Article
ISSN: 0305-1870
DOI: 10.1111/j.1440-1681.2012.05695.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PATIENT AWARENESS OF SUSTAINED COMMITMEN

PATIENT AWARENESS OF SUSTAINED COMMITMENT TO CLOPIDOGREL USE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR TREATMENT OF CORONARY HEART DISEASE IN THE CONTEMPORARY ERA

✍ M. Fuad Jan; Harold Elias; Naoyo Mori; Hina Mahboob; Anjan Gupta; Tanvir Bajwa; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 151 KB

USEFULNESS OF ANTICOAGULANT THERAPY FOR

USEFULNESS OF ANTICOAGULANT THERAPY FOR ATRIAL FIBRILLATION IN CHRONIC KIDNEY DISEASE PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH STENTING

✍ Yusuke Iwasaki; Takahisa Yamada; Yuji Okuyama; Takashi Morita; Yoshio Furukawa; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Usefulness of Preprocedural Soluble CD40

Usefulness of Preprocedural Soluble CD40 Ligand for Predicting Restenosis After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease

✍ Sonay Türker; Sema Güneri; Bahri Akdeniz; Mehmet Ali Özcan; Nezihi Barıs; Özer B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Effect of cytochrome P450 3A5 polymorphi

Effect of cytochrome P450 3A5 polymorphism on platelet reactivity after treatment with clopidogrel in patients scheduled for percutaneous coronary intervention

✍ Abeer A. Saad; Ahmed M. Abd Elsalam; Gihan M. Kamal; Nahla F. Abou El-Ezz; Rehab 📂 Article 📅 2011 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 489 KB

TCT-527: Percutaneous Coronary Intervent

TCT-527: Percutaneous Coronary Interventions In Patients with Anti-vitamin K Treatment: Long-term Results Of a Novel Strategy Using Endothelial Progenitor Cells (EPC) Capture Stent

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 238 KB

PCV9 Optimal Treatment Shortfalls and Wo

PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practice: Data from the Multinational, Prospective, Antiplatelet Treatment Outcomes Registry (APTOR)

✍ S. James; A. Iniguez; G. Pavlides; U. Zeymer; M. Sartral; M. Belger; M.E. Tomlin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB